Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement

Clinical trial NCT00573326 · UNKNOWN

Trial details

NCT number: NCT00573326
Sponsor: Azienda Ospedaliera Universitaria Policlinico
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2009-02-01
Primary completion: 2010-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.